CS

Chandra Sekhar Gannamaneni

Active Director Managing Director DIN 02385680
DIN 02385680 First appointment Aug 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Aug 1994
Shareholding value •••• Premium profile

About Chandra Sekhar Gannamaneni

Data last updated:

Chandra Sekhar Gannamaneni is a Managing Director at Neospark Drugs And Chemicals Private Limited (since 1994) and Managing Director at Neospark Pharma Private Limited (since 1994). The companies operate in Pharma and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹229 Cr; the largest is Neospark Drugs And Chemicals Private Limited at ₹228 Cr (FY 2025). Earlier, Chandra Sekhar Gannamaneni was a Director at Neeli Aqua Private Limited (2005–2012) and Director at Neospark Aquatech Private Limited (from 1994) and 1 more.

DIN 02385680
Primary Designation Managing Director
Industry Pharma
First Appointment 17 Aug 1994
Oldest Company Age 37 yrs
Largest company Neospark Drugs And Chemicals Private Limited · ₹228 Cr (FY 2025)
Combined revenue ₹229 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director17 Aug 19941989₹228 Cr (FY 2025)Active
Neospark Pharma Private Limited U24230TG1994PTC018667
Managing Director01 Nov 19941994₹53.2 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neeli Aqua Private Limited U05004AP2005PTC048017
Director10 Nov 20052005₹80.64 Cr (FY 2025)Active
Neospark Aquatech Private Limited U05005TG1994PTC018670
Director01 Nov 19941994Strike Off
Neospark Organics Private Limited U24116TG1994PTC018663
Director01 Nov 19941994Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neospark Aquatech Private Limited
Neospark Organics Private Limited
Neospark Drugs And Chemicals Private Limited
Neospark Pharma Private Limited
Premium access

Shareholding and investment profile for Chandra Sekhar Gannamaneni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Sekhar Gannamaneni

Chandra Sekhar Gannamaneni currently holds 2 directorships: Neospark Drugs And Chemicals Private Limited (Managing Director, since 17 Aug 1994, revenue ₹228 Cr (FY 2025)); Neospark Pharma Private Limited (Managing Director, since 01 Nov 1994, revenue ₹53.2 Lakh (FY 2025)).

Chandra Sekhar Gannamaneni was first appointed on 17 Aug 1994 as Managing Director at Neospark Drugs And Chemicals Private Limited. The most recent appointment on record is 10 Nov 2005 at Neeli Aqua Private Limited.

The 2 current companies of Chandra Sekhar Gannamaneni that report revenue have a combined latest revenue of ₹229 Cr: Neospark Drugs And Chemicals Private Limited ₹228 Cr (FY 2025); Neospark Pharma Private Limited ₹53.2 Lakh (FY 2025).

Chandra Sekhar Gannamaneni held 3 earlier board appointments: Neeli Aqua Private Limited (Director, 10 Nov 2005 to 27 Jul 2012); Neospark Aquatech Private Limited (Director, from 01 Nov 1994); Neospark Organics Private Limited (Director, from 01 Nov 1994).

The current boards of Chandra Sekhar Gannamaneni's companies include Ankamma Rao Uyyuru (Neospark Drugs And Chemicals Private Limited), Ashok Uyyuru (Neospark Drugs And Chemicals Private Limited), Gannamaneni Indrani (Neospark Drugs And Chemicals Private Limited), Hari Krishna Vemulapalli (Neospark Drugs And Chemicals Private Limited), Kalyan Kanaparti (Neospark Drugs And Chemicals Private Limited), Kumara Swamy Muppala (Neospark Drugs And Chemicals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available